Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
Clinical trial NCT00552565 · COMPLETED
Trial details
- NCT number
- NCT00552565
- Sponsor
- AGI Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-06-01
- Enrollment
- 711
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.